[Experience in complex therapy ribavine chronic viral hepatitis C].

In 72 patients with chronic hepatitis C aged 18 to 62 years evaluated the clinical efficacy Ribavine in combination therapy with interferon-alpha. The safety, good tolerability and efficacy Ribavine. Persistent virological and biochemical response in the application of interferon-alpha and Ribavine obtained from 47,5 to 53,1%.

[The mononuclear syndrome in yersiniosis and pseudotuberculosis].

As many as 95 patients with generalized form of yersiniosis and 66 patients with scarlatiniform pseudotuberculosis were examined. Atypical mononuclears were detected in the peripheral blood of 23.2% of patients with yersiniosis and 13.

[Variants in the manifestations of the generalized form of yersiniosis].

The clinical manifestations of generalized yersiniosis were studied in 61 patients. Primary generalized form was observed in 18 patients. Predecessors were gastroenteritis, appendicular syndrome.